Results 181 to 190 of about 1,519,714 (391)

Observations on the effects of the folic acid antagonists, aminopterin and amethopterin, in patients with advanced neoplasms [PDF]

open access: bronze, 1952
Emanuel B. Schoenbach   +2 more
openalex   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

open access: yesMolecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit   +19 more
wiley   +1 more source

Effects of Serotonin Antagonists in Normal Subjects and Patients with Carcinoid Tumors

open access: bronze, 1957
Roland E. Schneckloth   +3 more
openalex   +1 more source

Utilization of Stenotrophomonas koreensis and Bacillus amyloliquefaciens for Improving Growth, Reducing Nitrogen Fertilization and Controlling Bipolaris sorokiniana in Wheat

open access: yesCaraka Tani: Journal of Sustainable Agriculture
Wheat (Triticum aestivum L.), a vital cereal, faces significant challenges from common root rot and spot blotch diseases caused by Bipolaris sorokiniana.
Md. Motaher Hossain
doaj   +1 more source

Time, the final frontier

open access: yesMolecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain   +3 more
wiley   +1 more source

ANTAGONISTS OF NUCLEIC ACID DERIVATIVES

open access: hybrid, 1950
Gertrude B. Elion, George H. Hitchings
openalex   +1 more source

Targeting renal cell carcinoma with a HIF-2 antagonist

open access: yesNature, 2016
Wen-fang Chen   +33 more
semanticscholar   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy